714 related articles for article (PubMed ID: 12417659)
1. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
Allen B; Ingram E; Takao M; Smith MJ; Jakes R; Virdee K; Yoshida H; Holzer M; Craxton M; Emson PC; Atzori C; Migheli A; Crowther RA; Ghetti B; Spillantini MG; Goedert M
J Neurosci; 2002 Nov; 22(21):9340-51. PubMed ID: 12417659
[TBL] [Abstract][Full Text] [Related]
2. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M
Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM
Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524
[TBL] [Abstract][Full Text] [Related]
5. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein.
Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG
Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879
[TBL] [Abstract][Full Text] [Related]
8. Tau filament formation in transgenic mice expressing P301L tau.
Götz J; Chen F; Barmettler R; Nitsch RM
J Biol Chem; 2001 Jan; 276(1):529-34. PubMed ID: 11013246
[TBL] [Abstract][Full Text] [Related]
9. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
[TBL] [Abstract][Full Text] [Related]
10. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
Sahara N; Lewis J; DeTure M; McGowan E; Dickson DW; Hutton M; Yen SH
J Neurochem; 2002 Dec; 83(6):1498-508. PubMed ID: 12472903
[TBL] [Abstract][Full Text] [Related]
11. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.
Delobel P; Lavenir I; Fraser G; Ingram E; Holzer M; Ghetti B; Spillantini MG; Crowther RA; Goedert M
Am J Pathol; 2008 Jan; 172(1):123-31. PubMed ID: 18079436
[TBL] [Abstract][Full Text] [Related]
12. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
[TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
14. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
15. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-tocopherol on an animal model of tauopathies.
Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.
Tanemura K; Murayama M; Akagi T; Hashikawa T; Tominaga T; Ichikawa M; Yamaguchi H; Takashima A
J Neurosci; 2002 Jan; 22(1):133-41. PubMed ID: 11756496
[TBL] [Abstract][Full Text] [Related]
18. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.
Bellucci A; Westwood AJ; Ingram E; Casamenti F; Goedert M; Spillantini MG
Am J Pathol; 2004 Nov; 165(5):1643-52. PubMed ID: 15509534
[TBL] [Abstract][Full Text] [Related]
19. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
[TBL] [Abstract][Full Text] [Related]
20. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.
Spittaels K; Van den Haute C; Van Dorpe J; Bruynseels K; Vandezande K; Laenen I; Geerts H; Mercken M; Sciot R; Van Lommel A; Loos R; Van Leuven F
Am J Pathol; 1999 Dec; 155(6):2153-65. PubMed ID: 10595944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
